Steady buying (from frankly ridiculous levels - hope you bought more) in the last two weeks that seems to care little about the prevailing price offered.
We were told what? 3-4 weeks ago that the ATI vs surgery results were 'imminent'. We know J&J gets to look at them before they are disclosed to market.
A rather large elephant in the room hiding behind the faux fern?
In past partnerships, J&J usually takes a capital for share swap stake in the company, with initial and milestone payments to the partner. It utterly makes sense. J&J know the moment it announces it sends the share price rocketing up. OCC goes from a company known by perhaps a few thousand investors to several hundred. My fingers are crossed for a partnership on not just an investment perspective but of course getting ATI to market at long last and patients with presently questionable and arduous standard of care outlooks benefitting as I did personally from ATI.
OCC Trading, page-1519
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.010(2.63%) |
Mkt cap ! $81.63M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 39.0¢ | 37.5¢ | $49.66K | 129.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 20305 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 77938 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |